Generalized myositis mimicking polymyositis associated with chronic active Epstein-Barr virus infection

Tomoyuki Uchiyama1, Kimito Arai, Takako Yamamoto-Tabata

  • 1Dept. of Neurology, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan. uchiyama@faculty.chiba-u.jp

Journal of Neurology
|March 3, 2005
PubMed
Abstract

Insights

Chronic active Epstein-Barr virus infection (CAEBV) can cause a new form of chronic generalized myositis. This condition mimics polymyositis and requires specific diagnostic investigation, especially with lingual or orbital involvement.

Area of Science:

  • Immunology
  • Neurology
  • Virology

Background:

  • Chronic generalized myositis is a newly identified complication of chronic active Epstein-Barr virus infection (CAEBV).
  • This condition presents clinically similar to polymyositis but has distinct pathological features.

Observation:

  • Three patients with CAEBV presented with chronic generalized myositis, two with initial proximal weakness and muscle atrophy, and one with late-stage generalized myositis.
  • Lingual and/or orbital myositis were observed in some patients, differentiating it from typical polymyositis.
  • Immunotherapy proved ineffective, and the prognosis was poor across all cases.

Findings:

  • Muscle biopsies revealed infiltrating lymphocytes characterized as CD45RO+, CD3+, CD4-, CD8-, TCR betaF1-, TCR deltaTCS1-, CD56-, CD79a-, CD21-, HLA-DR+, ZEBRA-, LMP1-, and EBER+ T cells.
  • Evidence of oligoclonal expansion of Epstein-Barr virus-infected T cells was found within the muscle tissue.
  • No malignant lymphocytes were detected, ruling out a neoplastic process.

Implications:

  • This distinct myositis entity necessitates differentiation from polymyositis and other conventional myopathies.
  • Clinicians should consider investigating for occult CAEBV in patients with steroid-nonresponsive chronic progressive generalized myositis, particularly those with lingual or orbital involvement.

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...